Arthur B. Page’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$890K Sell
10,214
-635
-6% -$54.2K 0.92% 31
2023
Q4
$894K Sell
10,849
-2,838
-21% -$216K 0.94% 32
2023
Q3
$1.07M Buy
13,687
+46
+0.3% +$3.85K 1.11% 31
2023
Q2
$1.2M Buy
13,641
+258
+2% +$22.2K 1.14% 32
2023
Q1
$1.08M Buy
13,383
+2,470
+23% +$201K 1.01% 32
2022
Q4
$848K Sell
10,913
-1,852
-15% -$150K 0.83% 35
2022
Q3
$1.03M Buy
12,765
+4,028
+46% +$362K 1.08% 34
2022
Q2
$784K Buy
8,737
+5,150
+144% +$522K 0.74% 38
2022
Q1
$398K Buy
+3,587
New +$379K 0.31% 47

Other funds holding MDT

Arthur B. Page's MDT Position: Q1 2024 in Review

Arthur B. Page reduced its Medtronic (MDT) stake by 5.9% in Q1 2024, selling an estimated $54.2K and leaving 10,214 shares worth $890K. The position accounts for 0.92% of the portfolio, ranked #31.

Arthur B. Page first reported a position in MDT in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.2M in Q2 2023. 2,081 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Arthur B. Page held 10,214 shares of Medtronic worth $890K as of Q1 2024.
  • Arthur B. Page sold 635 Medtronic shares in Q1 2024, an estimated $54.2K.
  • Medtronic made up 0.92% of Arthur B. Page's portfolio in Q1 2024, its #31 holding.
  • Arthur B. Page first reported a position in Medtronic in Q1 2022 and has held it in 9 quarters since.
  • Arthur B. Page's Medtronic position peaked at $1.2M in Q2 2023.
  • 2,081 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Arthur B. Page's 13F filing for Q1 2024, filed 29 Apr 2024.